Correlogic and Matsui Renew Japanese Cancer Partnership | GenomeWeb
NEW YORK (GenomeWeb News) — Clinical proteomics company Correlogic Systems today said it has renewed a research collaboration and signed a new agreement with Japanese company Mitsui.
 
The new deal extends a relationship begun in 2004 when the companies signed an exploratory agreement to use Correlogic's pattern-recognition approach and technology to detect ovarian cancer in Japanese women. 
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.